LONDON, March 24 -- The government of the United Kingdom issued the following news:
Following the update published on 27 February 2026, we are publishing, for transparency, a copy of an email sent to all MHRA staff by Chief Executive Lawrence Tallon on 11 March 2026, regarding the Pathways clinical trial.
A copy of the email is available here:
MHRA staff email - 11 March 2026 (PDF, 125 KB, 2 pages)
Disclaimer: Curated by HT Syndication.
